SEVOFLO DIN 02308355
Health Canada record
| Active ingredient(s) | SEVOFLURANE 100 % |
|---|---|
| Dosage form | Liquid |
| Route | Inhalation |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SEVOFLURANE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02265974 | SEVOFLURANE | BAXTER CORPORATION | Liquid | SEVOFLURANE 99.97 % | Marketed |
| 02307766 | SEVOFLURANE | PIRAMAL CRITICAL CARE INC | Liquid | SEVOFLURANE 99.97 % | Marketed |
| 02553449 | SEVOFLURANE | BLUE-ZONE TECHNOLOGIES LTD | Liquid | SEVOFLURANE 99.9875 % | Approved |
| 02172763 | SEVORANE AF | ABBVIE CORPORATION | Liquid | SEVOFLURANE 99.97 % | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 17439 | 2015-11-05 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 9456 | 2008-03-28 | New Drug Submission (NDS) |
International API supply for SEVOFLURANE
2 valid EDQM Certificates of Suitability from 2 holders. 6 active FDA Drug Master Files.
Request a quote for SEVOFLO